Effect of probucol on the concentration of cyclosporin A in patients with nephrotic syndrome

The first choice of therapy for nephrotic syndrome is steroid, and cyclosporin A (CyA) or other immunosuppressants are selected for steroid resistant or recurrent cases. Nephrotic syndrome accompanies hyperlipidemia for which HMG-CoA reductase inhibitors are mainly used. On the other hand, probucol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nihon Jinzo Gakkai shi 2001/10/25, Vol.43(7), pp.595-599
Hauptverfasser:	WAKASUGI, Hiroko, YOSHIMOTO, Mani, AOKI, Maki, OSAWA, Riyo, FUTAMI, Takahiro, ONO, Takahiko, MUSO, Eni, INUI, Ken-ichi
Format:	Artikel
Sprache:	jpn
Schlagworte:	Adult Aged Anticholesteremic Agents - therapeutic use cyclosporin A, probucol, drug interaction, nephrotic syndrome, hyperlipidemia Cyclosporine - administration & dosage Cyclosporine - blood Drug Interactions Drug Therapy, Combination Female Humans Hyperlipidemias - complications Hyperlipidemias - drug therapy Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - blood Male Middle Aged Monitoring, Physiologic Nephrotic Syndrome - complications Nephrotic Syndrome - drug therapy Probucol - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!